Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:B7E - DE000A0JM2M1 - Common Stock

17.5 EUR
-0.6 (-3.31%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

5

Overall B7E gets a fundamental rating of 5 out of 10. We evaluated B7E against 120 industry peers in the Capital Markets industry. While B7E has a great profitability rating, there are some minor concerns on its financial health. B7E is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year B7E was profitable.
B7E had a positive operating cash flow in the past year.
B7E had positive earnings in 4 of the past 5 years.
Each year in the past 5 years B7E had a positive operating cash flow.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.48%, B7E belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
B7E has a Return On Equity of 20.25%. This is amongst the best in the industry. B7E outperforms 83.33% of its industry peers.
With a decent Return On Invested Capital value of 6.33%, B7E is doing good in the industry, outperforming 72.50% of the companies in the same industry.
B7E had an Average Return On Invested Capital over the past 3 years of 5.02%. This is below the industry average of 9.23%.
The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

B7E's Profit Margin of 11.71% is in line compared to the rest of the industry. B7E outperforms 52.50% of its industry peers.
In the last couple of years the Profit Margin of B7E has grown nicely.
B7E has a Operating Margin of 8.02%. This is comparable to the rest of the industry: B7E outperforms 55.83% of its industry peers.
In the last couple of years the Operating Margin of B7E has grown nicely.
The Gross Margin of B7E (49.70%) is better than 63.33% of its industry peers.
In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
Compared to 5 years ago, B7E has more shares outstanding
Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

B7E has an Altman-Z score of 2.18. This is not the best score and indicates that B7E is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.18, B7E is doing good in the industry, outperforming 67.50% of the companies in the same industry.
The Debt to FCF ratio of B7E is 4.61, which is a neutral value as it means it would take B7E, 4.61 years of fcf income to pay off all of its debts.
B7E's Debt to FCF ratio of 4.61 is fine compared to the rest of the industry. B7E outperforms 73.33% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that B7E is not too dependend on debt financing.
B7E has a better Debt to Equity ratio (0.32) than 64.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.18
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

B7E has a Current Ratio of 1.73. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E has a better Current ratio (1.73) than 79.17% of its industry peers.
B7E has a Quick Ratio of 1.39. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E's Quick ratio of 1.39 is fine compared to the rest of the industry. B7E outperforms 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

B7E shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 292.72%, which is quite impressive.
Measured over the past years, B7E shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.00% on average per year.
Looking at the last year, B7E shows a decrease in Revenue. The Revenue has decreased by -0.59% in the last year.
B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

B7E is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -60.16% yearly.
The Revenue is expected to decrease by -5.47% on average over the next years.
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.47%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.88, the valuation of B7E can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 98.33% of the companies listed in the same industry.
B7E's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.57.
B7E is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 3.88
Fwd PE N/A
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 96.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, B7E is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.65
EV/EBITDA 2.96
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

B7E has a very decent profitability rating, which may justify a higher PE ratio.
B7E's earnings are expected to decrease with -60.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%

4

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.57%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.18, B7E pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.88, B7E pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.57%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

BLUE CAP AG

FRA:B7E (12/23/2025, 7:00:00 PM)

17.5

-0.6 (-3.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-26 2026-03-26/amc
Inst Owners25.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.58M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.86
Price Target30.87 (76.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.57%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.44%
PT rev (3m)-0.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.11%
EPS NY rev (3m)242.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.87%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 3.88
Fwd PE N/A
P/S 0.45
P/FCF 5.65
P/OCF 3.88
P/B 0.78
P/tB 1.49
EV/EBITDA 2.96
EPS(TTM)4.51
EY25.77%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)3.1
FCFY17.71%
OCF(TTM)4.51
OCFY25.8%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)N/A
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.18
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.47%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-0.64%
EBIT Next 3Y-20.6%
EBIT Next 5Y-13.28%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


What is the valuation status for B7E stock?

ChartMill assigns a valuation rating of 5 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Fairly Valued.


What is the profitability of B7E stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


Can you provide the financial health for B7E stock?

The financial health rating of BLUE CAP AG (B7E.DE) is 5 / 10.


Is the dividend of BLUE CAP AG sustainable?

The dividend rating of BLUE CAP AG (B7E.DE) is 4 / 10 and the dividend payout ratio is 0%.